Erratum: KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes (Proceedings of the National Academy of Sciences of the United States of America (2014) 111 (15078–15083) DOI: 10.1073/pnas.1318780111);KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 42, 2014, Pages 15078-15083

  Koh, Dong In ^a   Han, Dohyun ^b   Ryu, Hoon ^c   Choi, Won Il ^a   Jeon, Bu Nam ^a   Kim, Min Kyeong ^a   Kim, Youngsoo ^b   Kim, Jin Young ^d   Parry, Lee ^e   Clarke, Alan R ^e   Reynolds, Albert B ^f   Hur, Man Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Korea Basic Science Institute (KBSI)   (South Korea)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell cycle arrest; KAISO; P300; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; E1A ASSOCIATED P300 PROTEIN; PROTEIN P53; PUMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KAISO; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; DNA; EP300 PROTEIN, HUMAN; PROTEIN BINDING; TP53 PROTEIN, HUMAN; ZNF-KAISO PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY ASSAY; COMPLEX FORMATION; DNA DAMAGE; EMBRYO; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN ACETYLATION; PROTEIN DNA BINDING; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ACETYLATION; ANIMAL; C57BL MOUSE; CELL CYCLE; CELL LINE; CHEMISTRY; CYTOLOGY; DNA METHYLATION; DNA RESPONSIVE ELEMENT; FEMALE; HCT116 CELL LINE; KNOCKOUT MOUSE; METABOLISM; PROMOTER REGION;

ACETYLATION; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; DNA DAMAGE; DNA METHYLATION; E1A-ASSOCIATED P300 PROTEIN; FEMALE; FIBROBLASTS; HCT116 CELLS; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84908079433     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.2109163118     Document Type: Erratum

References (36)

1. Daniel JM, Reynolds AB (1999) The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19(5):3614-3623.
2. van Roy FM, McCrea PD (2005) A role for Kaiso-p120ctn complexes in cancer? Nat Rev Cancer 5(12):956-964.
3. Wade PA (2001) Methyl CpG-binding proteins and transcriptional repression. Bio-Essays 23(12):1131-1137.
4. Prokhortchouk A, et al. (2001) The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev 15(13):1613-1618.
5. Daniel JM, Spring CM, Crawford HC, Reynolds AB, Baig A (2002) The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res 30(13):2911-2919.
6. Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J (2003) N-CoR mediates DNA methylation-dependent repression through amethyl CpG binding protein Kaiso. Mol Cell 12(3):723-734.
7. Lopes EC, et al. (2008) Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines. Cancer Res 68(18):7258-7263.
8. Soubry A, et al. (2010) The transcriptional repressor Kaiso localizes at the mitotic spindle and is a constituent of the pericentriolar material. PLoS ONE 5(2):e9203.
9. Prokhortchouk A, et al. (2006) Kaiso-deficient mice show resistance to intestinal cancer. Mol Cell Biol 26(1):199-208.
10. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8(4):275-283.
11. Polager S, Ginsberg D (2009) p53 and E2f: Partners in life and death. Nat Rev Cancer 9(10):738-748.
12. Knights CD, et al. (2006) Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 173(4):533-544.
13. Appella E, Anderson CW(2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268(10):2764-2772.
14. Avantaggiati ML, et al. (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89(7):1175-1184.
15. Strasser A (2005) The role of BH3-only proteins in the immune system. Nat Rev Immunol 5(3):189-200.
16. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7(3):683-694.
17. Yu J, Zhang L (2008) PUMA, a potent killer with or without p53. Oncogene 27(Suppl 1):S71-S83.
18. Danial NN, Korsmeyer SJ (2004) Cell death: Critical control points. Cell 116(2):205-219.
19. MacLachlan TK, El-Deiry WS (2002) Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc Natl Acad Sci USA 99(14):9492-9497.
20. Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22(56):9030-9040.
21. Kelly KF, Daniel JM (2006) POZ for effect - POZ-ZF transcription factors in cancer and development. Trends Cell Biol 16(11):578-587.
22. Sansom OJ, Maddison K, Clarke AR (2007) Mechanisms of disease: Methyl-binding domain proteins as potential therapeutic targets in cancer. Nat Clin Pract Oncol 4(5):305-315.
23. Kruse J-P, Gu W (2009) Modes of p53 regulation. Cell 137(4):609-622.
24. Barlev NA, et al. (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8(6):1243-1254.
25. Burns TF, Bernhard EJ, El-Deiry WS (2001) Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene 20(34):4601-4612.
26. Fuchs EJ, McKenna KA, Bedi A (1997) p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. Cancer Res 57(13):2550-2554.
27. Levine AJ, Oren M (2009) The first 30 years of p53: Growing ever more complex. Nat Rev Cancer 9(10):749-758.
28. Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4(10):793-805.
29. Dai C, Gu W (2010) p53 post-translational modification: Deregulated in tumorigenesis. Trends Mol Med 16(11):528-536.
30. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature 387(6635):823-827.
31. Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90(4):595-606.
32. Puca R, et al. (2009) HIPK2 modulates p53 activity towards pro-apoptotic transcription. Mol Cancer 8(85):85.
33. Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9(5):402-412.
34. Kelly KF, Spring CM, Otchere AA, Daniel JM (2004) NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J Cell Sci 117(Pt 13):2675-2686.
35. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1(6):2856-2860.
36. Olsen JV, et al. (2009) A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed. Mol Cell Proteomics 8(12):2759-2769.